Bivalirudin versus Heparin in Primary Percutaneous Coronary Intervention- a Meta analysis

被引：0
作者：
Narayanan, Mahesh Anantha [1 ]
Reddy, Yogesh N. V. [2 ]
Anugula, Dixitha [3 ]
Gujjula, Nagarjuna [3 ]
Badheka, Apurva [4 ]
Deshmukh, Abhishek [2 ]
Kaushik, Manu [5 ]
Raveendran, Ganesh [6 ]
机构：
[1] Univ Minnesota, Roseville, MN USA
[2] Mayo Clin, Rochester, MN USA
[3] Creighton Univ, Med Ctr, CHI Hlth, Omaha, NE USA
[4] Everett Clin, Everett, WA USA
[5] NWI VA Med Ctr, Omaha, NE USA
[6] Univ Minnesota, St Paul, MN 55108 USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2016年 / 68卷 / 18期
关键词：
D O I：
10.1016/j.jacc.2016.09.298
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
TCT-156
引用
收藏
页码：B64 / B64
页数：1
相关论文
共 50 条
  • [21] Meta-Analysis of Effects of Bivalirudin Versus Heparin on Myocardial Ischemic and Bleeding Outcomes After Percutaneous Coronary Intervention
    Perez, Alberto E. Barria
    Rao, Sunil V.
    Jolly, Sanjit J.
    Pancholy, Samir B.
    Plourde, Guillaume
    Rimac, Goran
    Poirier, Yann
    Costerousse, Olivier
    Bertrand, Olivier F.
    AMERICAN JOURNAL OF CARDIOLOGY, 2016, 117 (08) : 1256 - 1266
  • [22] Benefit of Bivalirudin Versus Heparin After Transradial and Transfemoral Percutaneous Coronary Intervention
    MacHaalany, Jimmy
    Abdelaal, Eltigani
    Bataille, Yoann
    Plourde, Guillaume
    Duranleau-Gagnon, Pierre
    Larose, Eric
    Dery, Jean-Pierre
    Barbeau, Gerald
    Rinfret, Stephane
    Rodes-Cabau, Josep
    De Larochelliere, Robert
    Roy, Louis
    Costerousse, Olivier
    Bertrand, Olivier F.
    AMERICAN JOURNAL OF CARDIOLOGY, 2012, 110 (12) : 1742 - 1748
  • [23] Comparison of patient outcomes with bivalirudin versus unfractionated heparin in percutaneous coronary intervention
    Watson, Kristin
    Seybert, Amy L.
    Saul, Melissa I.
    Lee, Joon Sup
    Kane-Gill, Sandra L.
    PHARMACOTHERAPY, 2007, 27 (05): : 647 - 656
  • [24] Heparin versus bivalirudin for percutaneous coronary intervention: has the debate come to an end?
    Elgendy, Islam Y.
    Capodanno, Davide
    JOURNAL OF THORACIC DISEASE, 2017, 9 (11) : 4305 - 4307
  • [25] Platelet Activity in Primary Percutaneous Coronary Intervention Patients Randomized to Bivalirudin or Heparin
    Venetsanos, Dimitrios
    Swahn, Eva
    Lawesson, Sofia Sederholm
    Gustafsson, Kerstin M.
    Erlinge, David
    Lindahl, Tomas L.
    Alfredsson, Joakim
    CIRCULATION, 2017, 136
  • [26] A meta-analysis and cost-minimization analysis of bivalirudin versus heparin in high-risk patients for percutaneous coronary intervention
    Sun, Ke-Xin
    Cui, Bin
    Cao, Shan-Shan
    Wang, Wen-Jun
    Yu, Feng
    Wang, Jing-Wen
    Ding, Yi
    PHARMACOLOGY RESEARCH & PERSPECTIVES, 2021, 9 (03):
  • [27] Efficacy and safety of bivalirudin versus heparin in patients undergoing percutaneous coronary intervention: A meta-analysis of randomized controlled trials
    Zhang, Shuo
    Gao, Weihua
    Li, Haixia
    Zou, Meijuan
    Sun, Sihao
    Ba, Yijie
    Liu, Yang
    Cheng, Gang
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2016, 209 : 87 - 95
  • [28] Heparin Versus Bivalirudin in Acute Myocardial Infarction: Unfractionated Heparin Monotherapy Elevated to Primary Treatment in Contemporary Percutaneous Coronary Intervention
    Centurion, Osmar Antonio
    OPEN CARDIOVASCULAR MEDICINE JOURNAL, 2016, 10 : 122 - 129
  • [29] BIVALIRUDIN VERSUS UNFRACTIONED HEPARIN IN PATIENTS RECEIVING PERCUTANEOUS CORONARY INTERVENTION FOR ACUTE CORONARY SYNDROMES
    Farag, Mohamed
    Gorog, Diana
    Srinivasan, Manivannan
    HEART, 2015, 101 : A9 - A9
  • [30] BIVALIRUDIN VERSUS HEPARIN MONOTHERAPY IN PERCUTANEOUS CORONARY INTERVENTION PATIENTS: AN ANALYSIS OF ACUTE ADVERSE OUTCOMES AND COST
    Ephrem, Georges
    Guenoun, Jonathan
    Kim, Michael
    Jauhar, Rajiv
    Meraj, Perwaiz
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 65 (10) : A115 - A115
12345